Category Archives: Testosterone Replacement Therapy

Some men with a deficit of sex hormones who take testosterone replacement therapy may experience a benefit that goes beyond improved sexual function.

When men have both hypogonadism and poorly controlled type 2 diabetes, testosterone replacement therapy may improve both sexual function and cognitive function, according to preliminary results of a small clinical trial presented at the Endocrine Societys annual meeting in Atlanta.

The findings are welcome news to men with diabetes and hypogonadism, since they often have a poor quality of life, said the lead study author, Preethi Mohan Rao, MD, of the University of Sheffield, England, in a statement.

Hypogonadism in men, often called low T, develops when the body doesnt produce enough testosterone. While men can be born with the condition, it can also develop later in life and cause symptoms like reduced sex drive, erectile dysfunction, depression, and difficulty concentrating, according to the Mayo Clinic. Not all men with hypogonadism have symptoms, and testosterone replacement therapy is recommended only when they do, according to the Endocrine Society.

Sexual dysfunction is a common symptom of both hypogonadism and type 2 diabetes. Men with type 2 diabetes have about twice the risk of low testosterone, according to the American Diabetes Association. Men with poorly controlled diabetes or obesity, or both, have an even greater risk of low testosterone.

For the new clinical trial, researchers randomly assigned 65 men with hypogonadism and poorly controlled type 2 diabetes to take either placebo shots or injections of testosterone replacement therapy every 12 weeks for six months. Then researchers extended the trial for an additional six months, continuing treatment for men on testosterone and starting testosterone for men in the placebo group.

Over the first six months of the trial, men who took testosterone experienced significantly bigger improvements in quality of life and a larger reduction in symptoms associated with low testosterone.

When these men continued testosterone for an additional six months, they experienced overall symptom improvements as well as increased sexual function and libido, the trial found. In addition, these men performed significantly better on delayed verbal recall tests, assessments done to detect early signs of dementia.

The trial was small, however, and more research is needed before health practitioners change treatment approaches for men with hypogonadism and type 2 diabetes.

More:
Testosterone May Aid Memory in Men With Uncontrolled Diabetes - Everyday Health

DEAR DEIDRE: FOR the last ten months, my boyfriend has been secretly taking testosterone tablets and now Im worried he could be sterile.

Im 31 and hes 34. Weve been together for four years.

1

Listen to the NEW Dear Deidre podcast

Resident agony aunt Sally Land is taking The Sun's legendary advice column from the page to podcast.

Each week, Sally will be joined by an expert and some of your favourite celebs to give helpful, entertaining advice to listener problems.

A brand new episode will be available every THURSDAY.

Listen here, or wherever you get your podcasts: podfollow.com/1628340763

Last year he went through a rough patch. He had a stressful job and seemed constantly on edge.

He was almost never in the mood for sex and when he was, he couldnt get an erection. This only lasted six weeks.

I thought he was better because he changed jobs but it turns out hes been taking testosterone supplements.

I found his empty bottles of pills stuffed at the back of his wardrobe.

When I confronted him he admitted to buying them off the internet.

I cant believe hes been so stupid. Wed talked about having a baby soon but Ive read online that testosterone replacement therapy can leave him infertile.

Get in touch with Deidre

Every problem gets a personal reply, usually within 24 hours weekdays.

Ive told him he has to stop taking it but he wont listen.

He says without tablets he wont be himself any more.

DEIDRE SAYS:Try not to worry. In most cases, infertility caused by testosterone treatment is reversible once treatment is discontinued.

But its important that your boyfriend doesnt suddenly stop taking it in case he suffers side-effects.

Encourage him to speak to his GP, who can decide the best course of action.

Buying medication off the internet without a proper medical consultation can lead to more problems.

Im also attaching my pack, Want To Have A Baby?

Read this article:
Boyfriend has been secretly taking testosterone tablets and I worry he may go sterile... - The Sun

Aging can cause changes that may affect a persons sex life. Health conditions and changing hormone levels can impact a persons sex life, but people can take steps to maintain sexual satisfaction as they age.

Age does not have to limit a person sexually. Older people may actually experience a sense of liberation they did not in their youth, as responsibilities and the risks of unwanted pregnancy are lower.

This article looks at sex and aging, the changes to expect, and how people can lead a fulfilling sex life as they get older.

According to the National Institute on Aging (NIA), the normal aging process can bring about changes that may affect sex.

The sexual organs change with age. In females, the vagina may become narrower, with less lubrication. Menopause may also affect sexual desire. In males, erectile problems may become more common.

People may also find that physical changes, such as weight or muscle changes, affect how they feel in their bodies.

Illness, disability, medications, or surgery can also impact sexual desire and intimacy.

However, not all people experience these problems, and treatments are available for those who do.

Some researchers have studied sexual satisfaction in older adults and found positive results.

A 2019 survey of people 60 years and older found that sex was important to most people, with over 70% reporting being sexually attractive for their age.

Another 2019 study found that older adults reported no significant difference in intimacy. A third of older adults 6082 years reported more sexual thoughts and sexual activity than the average younger adult.

However, other factors can affect the sex lives of older adults.

The Health in Aging Foundation reports factors that may affect sex life as people age:

Some males may experience changes as they age. This section explains these changes in more detail.

Erectile dysfunction becomes more common in males as they age. People may find it harder to get and maintain an erection. People may also find an erection becomes less firm than it has been previously.

If erectile dysfunction becomes a regular occurrence, a person should consult a doctor.

A doctor can treat erectile dysfunction by prescribing medications such as Viagra.

Learn more about sexual health problems in males.

After the age of 50, some males may have a decrease in testosterone levels.

This may affect sex drive and the time it takes for people to become aroused and get an erection.

Erections may be less firm, may last for a shorter time than before, and it may take longer to ejaculate.

Learn more about hormonal changes in males.

People may feel differently about their bodies as they age, and a negative self-image may make them lose interest in sex or avoid being intimate with a partner.

Some females may experience changes as they age. This section looks at these changes in more detail.

In older age, the vagina can become shorter and narrower, with the vaginal wall becoming thinner and stiffer. There may also be less vaginal lubrication.

This may make vaginal penetration painful or reduce a persons desire to engage in certain sexual activities.

However, a person can use lubricants to help combat this issue.

Experiencing menopause can affect a persons sex life, as menopause causes hormone changes.

Some menopausal people may not notice any changes in their sex life, while others may experience:

A doctor can prescribe hormone replacement therapy to help relieve the symptoms of menopause.

A 2019 study found that in older females, factors for avoiding sex included:

Researchers found that, in older females, relationship factors had the same importance as health-related factors in sex avoidance.

Feeling uncomfortable about any bodily changes may impact intimacy and sex life.

People may find the following factors may help people to maintain a satisfying sex life as they age.

It is important to talk openly with a partner or partners about any changes or issues people are experiencing that may be affecting their sex life.

Discussing any sexual issues with a partner may help people increase intimacy and boost their sexual relationship.

Staying physically active and maintaining regular exercise will support heart health, strengthen muscles, and help mental health. People may find staying physically active helps them feel more interested in sex.

Masturbation may help people explore what they enjoy and become familiar with any changes in their sexual responses.

This may help people find it easier to communicate what they like to a partner. Masturbation may also help to boost well-being and improve body image and self-esteem.

Changing routines may help reinvigorate intimacy and sex.

Experimenting with new activities, positions, people, places, or fantasies may bring excitement to a persons sex life.

People may want to try new positions using pillows or wedges or try activities not involving the penis or vaginal penetration.

People may also like to explore role play, group sex, or try experiences with other genders than those they are used to.

However, those who are perimenopausal still need to use effective birth control if they do not wish to become pregnant. Males without a vasectomy also need to use contraception to prevent unwanted pregnancies.

Using barrier methods of contraception, such as condoms or dental dams, can help to prevent sexually transmitted infections.

If erectile dysfunction is affecting a persons sex life, medications may help, such as testosterone. It is important to discuss any potential side effects with a healthcare professional.

If sex is painful due to vaginal dryness, prescription hormones, such as vaginal estrogen, may help. People may also want to try over-the-counter water-based lubricants or moisturizers to help reduce dryness.

Hormone therapy may help symptoms of menopause and may help to increase sexual drive.

Talking with a counselor specializing in age, sex, and relationship issues may help people experiencing difficulties.

If there are problems with intimacy or sex in a relationship, it may be due to mental or emotional factors. Seeing a therapist, either individually or with a partner, may help to resolve these.

A therapist can also discuss aging concerns.

Learn more about improving a persons sex life.

Physical changes, medications or health conditions, hormone changes, and mental or emotional factors can affect a persons sex life as they age.

However, there are many steps people can take to enjoy a satisfying sex life as they age. Maintaining a healthy lifestyle, keeping active, and communicating clearly about how they feel about sex may help.

Medications or hormone therapy may also help with issues such as erectile dysfunction or menopause symptoms.

If people face issues with their sex life as they age, they may want to talk with a healthcare professional or counselor.

Continue reading here:
Sex and aging: Overview, stats, and maintaining satisfaction - Medical News Today

Caitlyn Jenner is 72, but if she ever decides to compete on the womens golf tour, watch out.

The transgender celebrity, who won the gold medal in the 1976 Olympic decathlon as Bruce Jenner, said Wednesday she can still hit a golf ball nearly 300 yards, seven years after undergoing a gender transition that included years of hormone therapy.

Ive been on for seven years of full transition, been on hormone replacement, and I can still hit the golf ball 280, 290 yards. Theres a lot left over, said Ms. Jenner on Fox News.

The average driving distance on the LPGA tour is about 250 yards. The longest driver on the tour is Emily Kristine Pedersen of Denmark, who averages 282 yards, according to the LPGA. On the mens tour, according to the PGA, the average drive for the 2021 season was 295.3 yards.

Ms. Jenners comment came in a discussion about former University of Pennsylvania swimmer Lia Thomas, who became in March the first male-born athlete to win an NCAA Division I womens title with a victory in the 500-yard freestyle.

Ive got a lot left over, and I think Lia Thomas obviously has a lot left over, said Ms. Jenner.

The debate over male-born athletes in womens sports reemerged Tuesday after Thomas said in interviews that transgender competitors are no threat to womens sports.

Im not a medical expert, but theres a lot of variation among cis female athletes, Ms. Thomas told ABC News. There are cis women who are very tall and very muscular and have more testosterone than another cis woman, and should that then also disqualify them?

Ms. Jenner has long argued, with medical support, that trans women who have undergone puberty have unfair physical advantages over their female competition.

She pinned the blame on the NCAA, which permitted Ms. Thomas to compete on the womens team in the 2021-22 season after undergoing more than a year of testosterone suppression.

Ms. Thomas had swam previously on the Penn mens team for three years, without coming close to winning any national titles.

Right now were living in this woke world that allows her to compete and win medals against biological women, Ms. Jenner said. Lia Thomas played by the rules, I have no problem with her, but what I have been urging from the beginning is that the NCAA change their policies to protect women in sports.

In January, the NCAA announced it would defer to national sports governing bodies on transgender competitors but then backtracked for the 2021-22 championships, saying it would be unfair to change the rules on athletes mid-season.

When you transition, you have to have some integrity, and I think in some cases that may be lacking here, Ms. Jenner said. But she [Thomas] did play by the rules.

See more here:
Caitlyn Jenner can still hit golf ball nearly 300 yards after transitioning to female - Washington Times

This past spring, a small group of women gathered at the Beaverbrook estate in Surrey, England, a 470-acre country idyll outside London that once received guests including Elizabeth Taylor and Ian Fleming. The sprawling property, which has become a destination for wellness programs featuring everything from lectures on traditional Chinese massage to Wim Hofs cold plunges, had lured attendees for a womens health retreat. The topics included abdominal massage therapy and guided talks on depleted estrogen. This is the first time there have been so many of us, gut-health expert Amanda Porter relayed to the group, adding the staggering statistic that nearly 1 billion women are projected to experience the onset of symptoms including hot flashes and brain fog by 2025. They are the many, the confused, the perimenopausal.

Think of it like puberty, says Jen Gunter, MD, a Canadian American gynecologist and the author of The Menopause Manifesto. There isnt really a hard start date, and you dont know that youre in it until youre really in it. She goes on to describe an often undiagnosed panoply of symptoms associated with perimenopause, which precedes menopause (when youve gone 12 consecutive months without menstruating) and can start as early as our mid-30s: cycle irregularities, increased anxiety and depression, insomnia, night sweats, weight gain, a decimated sex drive. A lack of visibility doesnt help. When I turned 43, feeling wholly unequipped for my own experience with mood swings and spontaneously heavy periodsand with no guidance from my doctorI found myself googling flash periods after an episode of And Just Like That (the one where Charlotte memorably bleeds through a white jumpsuit at a charity paint party). There was just this lack of information and support, agrees the actor Naomi Watts when we spoke about the topic earlier this year. Id had enough. This September, Watts will join an increasingly vocal group of entrepreneurs, celebrities, and medical providers determined to change that dynamic when she launches a new perimenopause- and menopause-focused wellness brand with Bay Area biotech company Amyris.

Its true that hormonestheir unpredictability, and their ripple effect on how we look and feelare increasingly part of the beauty conversation. The first part of perimenopause is typically characterized by estrogen levels that fluctuate, but are still pretty high, and decreasing progesterone levels. And then the second part has to do with very rapidly declining estrogen, explains Anna Barbieri, MD, an ob-gyn at New Yorks Mount Sinai Hospital. Hormone replacement therapy (HRT), in which synthetic versions of these hormones can bolster dwindling supplies, remains a tried-and-true course of treatment. Every single one of us whos entering this transition or going through it should know about the option of hormone therapy and its risks and benefits, says Barbieri, who is also the founding physician of Elektra Health, a digital womens health platform offering virtual one-on-one menopause care with accredited providers and accountability counselors known as menopause doulas. But now there are also products such as Kindras hot flash and night sweatmitigating Cool Down Mist; Wiles Drinking Your Feelings, a stress-reducing adaptogen powder that can be mixed into your daily matcha; and the skin-calming Meditation Gel Cream from Knours, an entire skin-care range tailored to fluctuating cycles. Veracity, a six-piece skin-care line formulated to support tangential issues, including excess oil production and thinning skin, recently inspired a Hormone Balancing Facial at The Well, Manhattans buzzy destination for mindful beauty. A 60-minute treatment left my skin far less inflamed than usual, and my soul soothed.

Despite an uptick in home diagnostic tests from Thriva and Everlywell, there is no clinically proven way to test for perimenopause. Somebody who tells you we can just measure your estrogen and progesterone is bullshitting you, says Alicia Jackson, PhD, the founder of Evernow, a telehealth company that aims to provide patients with 24/7 online perimenopause support as well as virtual hormone therapy plans. Thats because our hormone levels during this transition vary wildly from day to day, so testing them to get a quantifiable diagnosis isnt reliable. Theres no established value for them, agrees Barbieri. What hormone testing can help with, she says, is to rule out other conditions (like thyroid abnormalities, for instance) that can often pose as perimenopause. Somi Javaid, MD, a Cincinnati-based ob-gyn, uses hormone tests at HerMD, the medical practice she runs in Ohio and Kentucky, for a different reason: If women see that their FSH [follicle-stimulating hormone], which is responsible for controlling our menstrual cycles, is going up and their estrogen and testosterone are going down, I may not be able to tell them theyre perimenopausal, but it helps them understand that somethings going on, says Javaid, adding that this kind of validation is extremely important: So many women who complain about perimenopause symptoms are being dismissed.

According to a recent report published in The New York Times, female patientsand particularly women of colorare far more likely than men to experience a kind of medical gaslighting (in which legitimate symptoms are invalidated by doctors); when it comes to perimenopause, that brush-off may be even more widespread. Stacy London experienced this firsthand. The longtime fashion stylists hormonal transition at age 46 had a number of typical markers. I started to feel anxiety all the time, my skin got worse, my joints felt sore, I had insomnia and terrible brain fog, says London. I thought my brain was short-circuiting, because I couldnt remember words. Londons doctor recognized her symptoms but provided little recourse for treatment. She said, Its just menopause, youll get through it, London recalls. The experience compelled her to join State Of, a skin- and body-care line that she became the CEO of in 2021, which aims to give the menopause transition a makeover, one cheerily packaged tube of joint cream at a time.

Excerpt from:
Once a Taboo Topic, Menopause Is (Finally) Having Its Wellness Moment - Vogue

Shares of Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT Get Rating) have been assigned an average recommendation of Buy from the six ratings firms that are presently covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a buy recommendation. The average 1-year price objective among analysts that have covered the stock in the last year is $6.88.

A number of brokerages have issued reports on CRXT. Maxim Group decreased their price objective on Clarus Therapeutics to $1.50 in a research report on Thursday. Zacks Investment Research raised Clarus Therapeutics from a hold rating to a buy rating and set a $1.75 target price on the stock in a research note on Monday, April 4th. Needham & Company LLC dropped their price objective on Clarus Therapeutics to $3.00 and set a buy rating on the stock in a research note on Tuesday, May 17th. Finally, Truist Financial dropped their target price on Clarus Therapeutics from $7.00 to $3.00 and set a na rating on the stock in a research report on Tuesday, May 17th.

A number of hedge funds have recently modified their holdings of CRXT. Verition Fund Management LLC acquired a new stake in Clarus Therapeutics during the 3rd quarter worth about $160,000. UBS Group AG acquired a new stake in Clarus Therapeutics during the 3rd quarter worth about $206,000. Telemetry Investments L.L.C. acquired a new stake in Clarus Therapeutics during the 3rd quarter worth about $240,000. Powell Investment Advisors LLC grew its position in Clarus Therapeutics by 48.8% during the 4th quarter. Powell Investment Advisors LLC now owns 64,000 shares of the companys stock worth $156,000 after purchasing an additional 21,000 shares during the period. Finally, Citadel Advisors LLC acquired a new stake in Clarus Therapeutics during the 4th quarter worth about $31,000. Institutional investors own 19.50% of the companys stock.

Clarus Therapeutics (NASDAQ:CRXT Get Rating) last posted its earnings results on Monday, May 16th. The company reported ($0.61) EPS for the quarter. The company had revenue of $4.01 million during the quarter. On average, equities research analysts anticipate that Clarus Therapeutics will post -1.22 EPS for the current year.

Clarus Therapeutics Company Profile (Get Rating)

Clarus Therapeutics Holdings, Inc, a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill's proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans.

Further Reading

Receive News & Ratings for Clarus Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clarus Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.

Read the original here:
Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) Receives $6.88 Consensus PT from Analysts - Defense World

Juvenile Macular Degeneration Treatment: Introduction

Juvenile macular dystrophy, also known as juvenile macular degeneration, refers collectively to a group of rare and genetic inherited eye disorders that can affect children and young adults. Juvenile macular dystrophy involves the deterioration of the eyes macula; however, it is different from age-related macular degeneration (AMD).

Read Report Overview http://www.transparencymarketresearch.com/juvenile-macular-degeneration-treatment-market.html

AMD occurs as part of the bodys natural aging process and affects older adults; however, juvenile macular dystrophy is an inherited condition, which primarily targets the vision of children, teens, and young adults.

Key Drivers and Restraints of Global Juvenile Macular Degeneration Treatment Market

Increase in R&D activities, rise in number of patients suffering from diseases, and rapid expansion of health care and biopharmaceutical industries in developed and developing countries are anticipated to propel the global advancements in therapies in the juvenile macular degeneration treatment market during the forecast period. In June 2018, Lin BioScience granted orphan drug designation to LBS-008, a first-in-class oral therapy, for the treatment of Stargardt Disease by the European Medicines Agency.

Request a PDF Brochure https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=77631

Juvenile macular degeneration is currently an untreatable inherited condition that causes permanent vision loss in children during childhood and adolescence. Stargardt disease is the most common form of juvenile macular degeneration that affects approximately 37,000 individuals in the U.S. and 66,000 in the EU. Currently, there is no approved treatment for Stargardt patients. The disease is caused due accelerated formation and accumulation of toxic vitamin A dimers in the retina caused due mutation in the ABCA4 gene, which cause progressive retinal cell death. Consequently, this process eventually leads to legal blindness with only peripheral vision remaining.

Increase in the number of eye care centers has been recorded, since primary eye care is presently taken care of in optical shops. New optical shops have the latest technological devices that improve user friendliness. Rise in the number of optical shops, eye care centers, and hospitals has increased the availability of treatment.

Request for Analysis of COVID19 Impact on Juvenile Macular Degeneration Treatment Market https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=77631

In terms of end-user, the global juvenile macular degeneration treatment market can be categorized into hospitals, ophthalmic clinics, and ambulatory surgical centers. The hospitals segment accounted for a major share of the global macular degeneration treatment market. The segment is likely to maintain its leading position during the forecast period. A large population prefers to visit a hospital first rather than an ophthalmic clinic for treatment, as the cost of therapy at a hospital is lower. An ambulatory surgical center is a relatively less preferred option for the treatment of AMD.

Asia Pacific to Lead Global Juvenile Macular Degeneration Treatment Market

In terms of geography, the global juvenile macular degeneration treatment market can be segmented into five key regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are expected to hold major share of the global juvenile macular degeneration treatment market during the forecast period, owing to developed health care infrastructure and large patient population along with increasing technological development in these regions.

Increase in government intervention in emerging markets has led to a rise in awareness about diseases and improvement in health care infrastructure. Additionally, socioeconomic development has been observed in emerging economies such as Asia, Africa, and Latin America. These factors contribute to the overall increase in spending capacity of the population. Moreover, an increase in the foreign direct investment has been observed in these countries. This has led to various international players who are presently entering into these markets.

Pre Book Juvenile Macular Degeneration Treatment Market Research https://www.transparencymarketresearch.com/checkout.php?rep_id=77631&ltype=S

Key Players Operating in Global Juvenile Macular Degeneration Treatment Market

Manufacturers in the global juvenile macular degeneration treatment market are increasingly investing in research & development of new and innovative drugs such as Alkeus Pharmas lead compound, ALK-001; Katairo GmbH lead product, Remofuscin; Gene Therapy to Activate ABCA4 for Stargardt Disease and Recombinant Enzyme for Age Related Macular Degeneration and Stargardt Disease. These players are also focused on offering highly efficient and patient compliant products.

Leading companies operating in the global juvenile macular degeneration treatment market are:

More Trending Reports by Transparency Market Research

Opioid Tolerance Treatment Market: https://www.prnewswire.com/news-releases/overuse-of-opioids-for-pain-relief-stimulates-the-growth-of-global-opioid-tolerance-treatment-market-transparency-market-research-301004395.html

Surgical Robots Market: https://www.prnewswire.com/news-releases/surgical-robots-market-to-reach-us13-1-bn-by-2027-as-acceptance-jumps-high-in-emerging-regions-tmr-study-300997542.html

Synthetic Biology Market: https://www.prnewswire.com/news-releases/development-of-gene-editing-tools-for-treating-genetic-diseases-to-present-immense-growth-opportunities-for-synthetic-biology-market-growth-projected-at-whopping-26-3-cagr-from-2019-to-2027tmr-301273812.html

Teleradiology Market: https://www.prnewswire.co.uk/news-releases/rising-adoption-of-mhealth-technologies-changing-the-face-of-teleradiology-market-global-revenues-to-expand-at-cagr-of-16-9-from-2019-to-2027-says-tmr-891058992.html

Testosterone Replacement Therapy Market: https://www.prnewswire.co.uk/news-releases/sizeable-numbers-to-endorse-benefits-and-efficacy-of-umbrella-of-hormone-replacement-therapies-underscores-growth-in-testosterone-replacement-therapy-market-valuation-projected-to-touch-us-2-2-bn-by-2027-says-tmr-819153496.html

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Rohit BhiseyTransparency Market Research,90 State Street, Suite 700,Albany, NY 12207Tel: +1-518-618-1030USA Canada Toll Free: 866-552-3453Email: [emailprotected]Website:https://www.transparencymarketresearch.com/

Read more:
Juvenile Macular Degeneration Treatment Market Set to Grow According to Forecasts 2020 2030 Industrial IT - Industrial IT

The primary research analysis labelled Global Testosterone Replacement Therapy Market from 2022 to 2028, initially provided by MarketsandResearch.biz, is created with an excellent blend of operating characteristics, inventive solutions, possible solutions, and cutting-edge technology to provide a better user experience. The Testosterone Replacement Therapy market report covers a portfolio and performance comparison of the economys major companies, as well as commercial surveys, segment market share, geographic presence, planning processes, advancements, expansions, and technological developments.

The Testosterone Replacement Therapy Market research report keeps a close eye on crucial competitors through strategic analysis, internal and external market trends, pricing analysis, a full assessment of market circumstances, and the Testosterone Replacement Therapy Market research report keep a close watch on prominent competitors. A comprehensive study focuses on primary and secondary characteristics, market share, leading sectors, and regional analyses.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/253978

The Testosterone Replacement Therapy market research also includes a feasibility analysis of all segments and geographies, calculated based on their market size, growth rate, and attractiveness to present and prospective opportunists to forecast the future market growth.

Market segmentation based on the geographical boundaries:

The market has been reduced depending on

The market has been reduced as a result of

Market segmentation based on dominant players:

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/253978/global-testosterone-replacement-therapy-market-2022-by-manufacturers-regions-type-and-application-forecast-to-2028

The Testosterone Replacement Therapy Market research report closely monitors crucial competitors through corporate strategy, micro and macro market trends, pricing analysis, and a complete evaluation of market circumstances. The Testosterone Replacement Therapy Market research report keeps a close eye on crucial competitors.

The report offers thorough information on essential aspects impacting the growth of the global Testosterone Replacement Therapy market, such as drivers, constraints, opportunities, and industry-specific problems. This study aids in analyzing and projecting market size in terms of value and volume. The analysis forecasts the size of market segments in terms of value for the major geographies.

Customization of the Report:

This report can be customized to meet the clients requirements. Please connect with our sales team (sales@marketsandresearch.biz), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

Contact UsMark StoneHead of Business DevelopmentPhone: +1-201-465-4211Email: sales@marketsandresearch.biz

Continue reading here:
Testosterone Replacement Therapy Market 2022 to 2028 Global Industry Analysis, Growth, Trends and Forecast Queen Anne and Mangolia News - Queen Anne...

As of today, April 7, 2022, I have started on my journey for Hormone Replacement Therapy. I have thought long and hard about this decision for months now, and to overcome my body dysphoria I have decided that this is the best choice for me, personally.

That said, there is no right or wrong way to be transgender. You dont need surgery or HRT to feel happy as you are, and anyone who thinks different has a problem. Trans people do not need politicians, peers, or family speaking for what their experience should be or what it is, because thats our decision. Whether you wear a binder, walk around in a dress with a full beard, or dont really show the label, I stand by you.

Gender is a nuanced topic that no cis person can touch upon to the extent that a trans person could, and gender is not as simple as pink or blue, XX or XY chromosomes, penis or vagina. For the cis people that read this and feel like Im rehashing things thatve already been said, then get ready to hear it again because the world discriminating against us is very real and very lethal, and Im not going to stop advocating for trans rights even if I die at the hands of someone who sees me as a threat.

Im no threat, and I think theres much worse in the world than a person changing their gender, a choice that in no way affects another persons function.

Today, my doctors have prescribed me Estradiol in a 2-milligram pill to take daily. What I can expect from this is enlarged breasts, shrunken testicles, fewer erections, lower sex drives, mood swings, changes in fat distribution, and less muscle tone. These are all things I look forward to and accept; however, there is risk. These include threats to the cardiovascular system,

liver failure, and potential stroke. All of these are mitigated by the cessation of tobacco, exercise, and cardio which I do consistently enough for this to not be an issue.

Along with Estradiol, if I choose, I can also seek hormone blockers to make it so testosterone is not produced in my system. I have not thought about seeking these yet, because Id rather start slow.

All of this to say that this is my way of being trans. I am nonbinary, meaning I exist outside the spectrum of man or woman. Right now, I look like a man to those who arent in the know, and growing up this way made me uncomfortable in my own body. I take pride in my appearance and its hard to have pride when I look in the mirror and feel as though I am not within this skin that holds me.

Estradiol may change that to the point of people thinking I am a woman, and thats fine to me. Id rather look the way I chose to look, just as cis people would. Just because I have different genitals means nothing: There are women with penises and men with vaginas, and if people really want to try and define gender by genitals, then they need to talk to actual, modern biologists rather than relying on simple biology from high school textbooks desperately in need of being updated. Not only this, but there are intersex people to combat this idea persons born with varied anatomy so if we were really to link gender only to genitalia, then people wouldnt know where to put this differing factor.

NOT AN ENEMY

Although I may now hold the privilege to be proudly out of the closet and seeking medical transitioning, the current state of America is one of disarray, over deciding whether or not peoples decisions are their own to make, yet again.

As the powerful few try to talk over experiences theyve never had, people find themselves entrapped into calling LGBT people groomers or pedophiles, despite the fact that any person in the LGBT community will tell you that we dont align with these sickening criminals. This ideology is just spat out for the sake of creating enemies out of the people you likely share your work, classrooms, or home, with.

Whats more, the banning of gender affirmation therapy will not stop people from being trans, but could lead to a higher suicide rate and deterioration of mental health because gender affirmation therapy is the therapy needed for transgender people. And by that I dont mean that we stop being trans, but rather that we accept ourselves and feel brighter about our own future.

Im not going to stop being trans because a person tells me to, even if I got painful shocks into my head. This doesnt stop something that is completely natural. Thats a fact, even if it only antagonizes further the people in power who try to talk over us and mitigate our chances of life.

Even within our blue state here in Oregon, there is still ignorance we need to combat, as too many people still fear their own children coming out of the closet as something awful. Too many parents refuse to do basic research on the subject and instead let FOX News or Newsmax do the talking for them.

Alongside this, some people like to give money to media that are often aligned against trans people such as the work of famous author, known bigot, and loud voice in the fight to kill transgender people, J.K. Rowling. Rowling has been an advocate for trans exclusionary radical feminism, a flawed ideology that has played a key role in the passing of anti-trans and anti-LGBT legislation that seeks to define a woman solely by her reproductive property and nothing else, an ideology that many have described as hypocritical to feminism itself.

Within this realm of media that secretly punish LGBT youth comes Disney, which has been caught donating to several anti-trans and anti-LGBT legislators and lawmakers in Florida. These transactions have caused outrage among Disney consumers and Disney workers that has led to various strikes at Disney parks. Theres even been the advocation by Disney higher-ups demanding that workers remove any LGBT pins sold in their own stores and, in some cases, the termination of employees who have spoken against the companys terrible sense of decision-making.

Trans and LGBT rights have yet to finish coming, because until we are safe to walk in every state as open as we want to be without a bigot killing us, we are not safe. Neither are we some scary boogeyman thatll go away if you kill enough of us. Were people that you likely have a lot in common with, and maybe instead, you should listen to us.

More here:
Being trans and starting HRT - The Advocate

Toronto, Ontario

Toronto Functional Medicine Centre in Toronto, ON, Canada, has recently released a blog post that explains that the functional medicine approach to fertility in women is to check on DHEA levels. This is because DHEA is a hormone that plays a significant role in a science-based, patient-centered and individualized approach to fertility. It has been noted that DHEA levels decrease as women age and this can result in fertility issues. Women who have low ovarian reserve usually have low DHEA levels and research has revealed that DHEA supplementation may enhance fertility rates for these women. Furthermore, DHEA may help in boosting egg quality and boost the chances of successful pregnancy.

In functional medicine DHEA levels are indicative of a womans fertility. DHEA has been found to support fertility by helping with egg quality and enhancing pregnancy rates in women with diminished ovarian reserve (DOR). DOR is characterized by smaller follicles and a decline in ovarian follicular pool size at a particular age. Women with DOR typically produce a low optimal number of eggs, plus they also have poor quality embryos, with the result that they have decreased rates of implantation and pregnancy. An Anti-Mullerian Hormone (AMH) blood test must be performed to determine whether a woman has a low ovarian reserve.

Women with DOR typically have lower DHEA levels, which may be a significant factor in their poor response to fertility treatment. However, studies have shown that fertility treatments tend to be effective for women with low ovarian reserve if DHEA is used. This is because DHEA may help in enhancing egg quality through the promotion of follicular steroidogenesis. It increases IGF-1, which functions as a pre-hormone for follicular testosterone, decreasing aneuploidy while increasing the AMH and antral follicle count.

At the Toronto Functional Medicine Centre, their goal is to help patients boost their chances of getting pregnant and also to help them achieve optimal wellness. This is because they offer an integrative approach to functional medicine programs, which focus on traditional Chinese medicine, Western medicine/allopathic medicine, naturopathic medicine, bioidentical hormone replacement therapy, acupuncture, and herbal medicine. The philosophical basis of functional medicine is that every patient is a unique entity and functional medicine must address fertility by personalizing treatment plans for the patients specific biology only. Functional medicine testing may be used, including fertility-specific treatments with regards to lifestyle changes, nutritional deficiencies, chronic diseases, hormone imbalances, disease prevention, and more.

Toronto Functional Medicine Centre treats each patient as a unique whole person and their treatment methods are designed to restore cellular functioning and energy levels, while managing both the symptoms and the root cause of the health issue. They can address a broad variety of health problems, such as: brain health, adrenal fatigue, immunity, menopause, inflammation, chronic conditions, digestive health, detoxification, mold toxicity, hormone imbalances, nutritional deficiencies, food allergies or intolerance, thyroid malfunction, infertility, and more. Additionally, those interested can learn about the functional medicine approach to pcos from a previous article the clinic published.

The integrative care they provide to patients may include different strategies, including: traditional Chinese medicine, acupuncture for pain relief, naturopathic and herbal medicine, allopathic/western medicine, and medically-supervised IV therapy. And it should be pointed out that naturopathy integrates the traditional and natural forms of medicine with the latest scientific knowledge.

People who are interested in using DHEA for their fertility goals, should speak to their nurse practitioner and or medical doctor about functional medicine fertility support in Toronto. Those interested can also visit the Toronto Functional Medicine Centre website, or contact them on the phone (416) 968-6961 or through email at [emailprotected]. They are conveniently located at the heart of downtown Toronto.

###

For more information about Toronto Functional Medicine Centre, contact the company here:

Toronto Functional Medicine Centre(416) 968-6961[emailprotected]Toronto Functional Medicine Centre162 Cumberland St 222 AToronto, ON M5R 1A8

See original here:
DHEA Levels and Their Role in Fertility for Functional Medicine Patients - Digital Journal